Transaction · 0001193125-26-388156

Kim Lorence H.

Kim Lorence H., DIR, reported an open-market or private sale at Revolution Medicines, Inc. involving 4730.000000 shares for an estimated $995678.24. Reported holdings after the transaction were 4215.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
RVMDRevolution Medicines, Inc.
Trade date
Sep 08, 2026
Filing date
Sep 10, 2026
View on SEC Insider profile
Estimated value-$995kShares × reported price
Shares traded4.73k$210.50 per share
Holdings after4.21kIndirect · Trust
% of reported position traded52.88%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 8,945 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

RVMD price since this filing

Daily closing prices, with the filing date and available return windows
RVMD · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.9%1w ago +4.9%1d ago +3.3%
Returns since7d -3.2%30d -6.7%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-388156
Common Stock
Transaction date
Sep 08, 2026
Filed Sep 10, 2026, 09:52 PM · 2d delay
Shares
4,730 sh
$210.50 per share
Estimated value
-$995k
Computed from shares × price
Holdings after
4,215 sh
Indirect · Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Large Holdings Reduction Repeat Seller 10b5-1 Detected
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Includes 1,191 restricted stock units.

  2. F2

    Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026.

  3. F3

    The transaction was executed in multiple trades at prices ranging from $206.47 to $206.9903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Per…

  4. F4

    Shares held by the Lorence Kim Revocable Trust.

  5. F5

    The transaction was executed in multiple trades at prices ranging from $207.02 to $207.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Perso…

  6. F6

    The transaction was executed in multiple trades at prices ranging from $208.05 to $208.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Perso…

  7. F7

    The transaction was executed in multiple trades at prices ranging from $209.08 to $209.9809, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Per…

  8. F8

    The transaction was executed in multiple trades at prices ranging from $210.0114 to $210.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Per…

  9. F9

    The transaction was executed in multiple trades at prices ranging from $211.00 to $211.9425, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Per…

  10. F10

    The transaction was executed in multiple trades at prices ranging from $212.0775 to $212.3903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting P…

Original filing · 0001193125-26-388156
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

RVMD